North Carolina, Florida Home Health Agencies to See Changes in Review Choice Demonstration

The Centers for Medicare & Medicaid Services (CMS) announced this week that for home health providers subject to the Review Choice Demonstration (RCD) in North Carolina and Florida, the 25 percent payment reduction will be implemented for all claims submitted on or after April 1, 2022. This applies to home health agencies that selected Choice…

CMS Revises Review Choice Demonstration for North Carolina and Florida

Another big win for NAHC Advocacy! The Centers for Medicare & Medicaid Services announced Thursday, August 26, it is modifying the Review Choice Demonstration (RCD) in Florida and North Carolina, so that only those claims with dates of service beginning on and after September 1, 2021 will be subject to additional development request (ADR)/prepayment review if…

Review Choice Demonstration to be Fully Implemented in North Carolina, Florida

  Effective September 1, 2021, home health providers in North Carolina and Florida will see full implementation of the Review Choice Demonstration (RCD). RCD was originally scheduled to begin in the two states on May 4, 2020, but was delayed by the COVID-19 Public Health Emergency. Instead, a phased-in approach began in August 2020 allowing…

RCD Phase-in for Florida and North Carolina Renewed

The Centers for Medicare & Medicaid Services (CMS) announced a continuation of the phased-in participation of the Review Choice Demonstration (RCD) for home health agencies (HHAs) in Florida and North Carolina for an additional 90 days, due to the ongoing COVID-19 PHE. Providers interested in participating should make their Cycle 2 Choice selections between April…

CMS Extends Phased-in Review Choice Demonstraton in Florida & N. Carolina

The Centers for Medicare & Medicaid Services (CMS) announced on Thursday night, October 29, that due to the continuing public health emergency, CMS will be extending the phased-in participation in the Review Choice Demonstration (RCD) for Home Health Agencies in Florida and North Carolina until January 1, 2021. Providers may continue submitting pre-claim review requests. Claims…

CMS Makes Changes to the Review Choice Demonstration

Today the Centers for Medicare & Medicaid Services (CMS) announced a phased-in approach for the Review Choice Demonstration (RCD) for North Carolina and Florida. Both of these states were set to have RCD begin at the end of this month (See previous NAHC Report coverage here and here.)  CMS also posted a change to the…

CMS To Resume Medical Review Activities, Including Review Choice Demonstration

The Centers for Medicare & Medicaid Services (CMS) has announced the return of medical review activities, including the Review Choice Demonstration (RCD) program for home health services on August 3, 2020, regardless of the status of the Public Health Emergency (PHE). On March 30 the Centers for Medicare & Medicaid Services (CMS) suspended most Medicare…

CMS Announces Expansion of Review Choice Demonstration to More States

Texas starts in December, North Carolina and Florida in 2020 Updated to include a statement from NAHC President William A. Dombi The Centers for Medicare & Medicaid (CMS) announced today that the next state to participate in the Review Choice Demonstration (RCD) is Texas and it will begin on December 2, 2019. In the same…

CMS Acts to Support Victims of Hurricane Dorian

The Centers for Medicare & Medicaid Services (CMS) has announced efforts underway to support Florida, Georgia, and South Carolina in response to Hurricane Dorian. On August 30, Health and Human Secretary Alex Azar declared a public health emergency (PHE) in Florida. On September 2, Secretary Azar did the same for Georgia and South Carolina. CMS…

States Grapple with the Opioid Epidemic and Pain Management

Florida bill would make it easier to prescribe for hospice patients The opioid epidemic claims about 115 lives per day in the United States, a rate that has grown by 4000 percent since 1999. Nearly half of these opioid-related fatalities involve a prescription drug, according to the Centers for Disease Control and Prevention. In March…